Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, June 13, 2015 10:13:50 PM
bullish
## source: finance.yahoo.com
Fri, 12 Jun 2015 12:00:00 GMT ~ Xencor to Host R&D Day and Webcast on June 26, 2015
[PR Newswire] - MONROVIA, Calif., June 12, 2015 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, ...
read full: http://finance.yahoo.com/news/xencor-host-r-d-day-120000081.html
*********************************************************
Thu, 11 Jun 2015 20:17:48 GMT ~ XENCOR INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/150611/xncr8-k.html
*********************************************************
Wed, 10 Jun 2015 12:32:02 GMT ~ Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting
[at noodls] - MONROVIA, Calif., June 10, 2015 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, ...
read full: http://www.noodls.com/view/AA266D2A7FC4D8DB24C959D4C795C13E54201814
*********************************************************
Wed, 10 Jun 2015 12:01:19 GMT ~ XENCOR INC Files SEC form 8-K, Other Events
read full: http://biz.yahoo.com/e/150610/xncr8-k.html
*********************************************************
Wed, 10 Jun 2015 12:00:00 GMT ~ Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting
[PR Newswire] - MONROVIA, Calif., June 10, 2015 /PRNewswire/ -- Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today reported complete data results from a Phase 1b/2a study of XmAb®5871 in patients with rheumatoid arthritis (RA). XmAb5871 was generally well tolerated and showed trends in improvement in RA disease activity by multiple disease activity measures and across multiple dose groups. "These data demonstrate clear signs of disease modifying activity in a patient population with active disease while on non-biologic disease modifying anti-rheumatic drug (DMARD) therapy," said Bassil Dahiyat, Ph.D., president and chief executive officer of Xencor.
read full: http://finance.yahoo.com/news/xencor-reports-complete-data-results-120000838.html
*********************************************************
$XNCR charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$XNCR company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/XNCR/company-info
Ticker: $XNCR
OTC Market Place: Not Available
CIK code: not found
Company name: Xencor, Inc.
Incorporated In:
$XNCR share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$XNCR extra dd links
Company name: Xencor, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=XNCR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=XNCR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=XNCR+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/news - http://finance.yahoo.com/q/h?s=XNCR+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/XNCR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=XNCR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/XNCR
DTCC (dtcc.com): http://search2.dtcc.com/?q=Xencor%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Xencor%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Xencor%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/XNCR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=XNCR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=XNCR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=XNCR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=XNCR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=XNCR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=XNCR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=XNCR+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/XNCR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=XNCR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/XNCR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=XNCR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/XNCR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/XNCR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/XNCR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=XNCR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=XNCR
$XNCR DD Notes ~ http://www.ddnotesmaker.com/XNCR
Recent XNCR News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:02:16 PM
- Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares • Business Wire • 09/12/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 12:47:41 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/12/2024 12:45:12 PM
- Xencor Announces Pricing of $175 Million Public Offering of Common Stock • Business Wire • 09/11/2024 10:31:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/10/2024 08:34:11 PM
- Xencor Announces Proposed Public Offering of Common Stock • Business Wire • 09/10/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:00:54 PM
- Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs • Business Wire • 09/09/2024 11:31:00 AM
- Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024 • Business Wire • 09/06/2024 12:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 08:12:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:06:01 PM
- Xencor Reports Second Quarter 2024 Financial Results • Business Wire • 08/05/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 10:41:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/09/2024 08:18:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:25:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:24:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:23:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:20:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:03:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 12:05:23 PM
- Xencor Regains CD20 x CD3 Bispecific T-Cell Engager • Business Wire • 06/13/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:11:09 PM
- Xencor Reports First Quarter 2024 Financial Results • Business Wire • 05/09/2024 08:09:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:02:08 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM